Stifel on Outset Medical Inc. (OM): 'we expect this home hemodialysis agreement will be a positive incremental sales driver in 2025 and beyond'
Tweet Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $6.00 price target on Outset Medical Inc. (NASDAQ: OM).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
